Literature DB >> 27873108

Flushing in (neuro)endocrinology.

Fady Hannah-Shmouni1, Constantine A Stratakis2, Christian A Koch3,4.   

Abstract

Cutaneous flushing is a common presenting complaint in endocrine disorders. The pathophysiology of flushing involves changes in cutaneous blood flow triggered by multiple intrinsic factors that are either related to physiology or disease. Flushing can be divided into episodic or persistent causes. Episodic flushing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing results in a fixed facial erythema with telangiectasia and cyanosis due to slow-flowing deoxygenated blood in large cutaneous blood vessels. The differential diagnosis of cutaneous flushing in neuroendocrine disorders is limited, yet encompasses a broad spectrum of benign and malignant entities, including carcinoid syndrome, pheochromocytoma, Cushing syndrome, medullary thyroid cancer, and pancreatic neuroendocrine tumors. In this review, we provide a concise and up-to-date discussion on the differential diagnosis and approach of flushing in neuroendocrinology.

Entities:  

Keywords:  Carcinoid; Flushing; Histamine; Neuroendocrine tumor; Pheochromocytoma; Substance P

Mesh:

Year:  2016        PMID: 27873108      PMCID: PMC5161029          DOI: 10.1007/s11154-016-9394-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  62 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 2.  Differential diagnosis of the patient with unexplained flushing/anaphylaxis.

Authors:  D D Metcalfe
Journal:  Allergy Asthma Proc       Date:  2000 Jan-Feb       Impact factor: 2.587

Review 3.  Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.

Authors:  Alexander D J Baur; Marianne Pavel; Vikas Prasad; Timm Denecke
Journal:  Acta Radiol       Date:  2015-04-08       Impact factor: 1.990

Review 4.  Red face revisited: Flushing.

Authors:  Güliz İkizoğlu
Journal:  Clin Dermatol       Date:  2014-03-01       Impact factor: 3.541

5.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed?

Authors:  Volker F H Brauer; Gerhard H Scholz; Susanne Neumann; Tobias Lohmann; Ralf Paschke; Christian A Koch
Journal:  Endocr Pract       Date:  2004 Jan-Feb       Impact factor: 3.443

7.  Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases.

Authors:  E Crocetti; E Paci
Journal:  Eur J Cancer Prev       Date:  2003-06       Impact factor: 2.497

8.  Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome.

Authors:  Ali Afshari; Yasaman Ardeshirpour; Maya Beth Lodish; Evgenia Gourgari; Ninet Sinaii; Margaret Keil; Elena Belyavskaya; Charalampos Lyssikatos; Fatima A Chowdhry; Victor Chernomordik; Afrouz A Anderson; Thomas A Mazzuchi; Amir Gandjbakhche; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-08-24       Impact factor: 5.958

9.  Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma.

Authors:  K Kitamura; K Kangawa; M Kawamoto; Y Ichiki; H Matsuo; T Eto
Journal:  Biochem Biophys Res Commun       Date:  1992-05-29       Impact factor: 3.575

10.  Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence.

Authors:  Konstanze Miehle; Andrea Tannapfel; Peter Lamesch; Gudrun Borte; Eva Schenker; Regine Kluge; Rudolf A Ott; Volker Wiechmann; Martin Koch; Woubet Kassahun; Ralf Paschke; Christian A Koch
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  19 in total

Review 1.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

3.  Metabolism and skin diseases.

Authors:  Christos C Zouboulis; Constantine A Stratakis; George P Chrousos; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 4.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

5.  Editorial : Neuroendocrine neoplasms.

Authors:  Christian A Koch; Stephan Petersenn
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 6.  Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?

Authors:  Christian Fottner; Martina Ferrata; Matthias M Weber
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 7.  Management of pulmonary neuroendocrine tumors.

Authors:  Robert A Ramirez; Aman Chauhan; Juan Gimenez; Katharine E H Thomas; Ioni Kokodis; Brianne A Voros
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 8.  Skin manifestations of Cushing's syndrome.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 9.  Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.

Authors:  Giuseppe Fanciulli; Rosaria M Ruggeri; Erika Grossrubatscher; Fabio Lo Calzo; Troy D Wood; Antongiulio Faggiano; Andrea Isidori; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 10.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.